Showing results (1-10 of 222) with videos related to
Sort By:
Pageof 23
Internal Medicine Journal|September 9, 2024
Clinical perspectives: Takotsubo cardiomyopathyJayant Ravindran, David BriegerThe Canadian Journal of Cardiology|July 8, 2026
Association of atrial fibrillation status with risk of strokes, mortality and cardiovascular outcomes in patients undergoing coronary artery bypass graftingAimy Yan, Jayant Ravindran, Vincent Chow, et al.CJC Open|July 23, 2025
Impact of Coronary Intervention on In-Hospital Mortality in Octogenarians and Nonagenarians, Compared to Elderly Patients Aged < 80 Years with Acute Coronary SyndromesJayant Ravindran, David Brieger, Karice Hyun, et al.BMJ Open|December 17, 2025
Prognosis of patients hospitalised with primary or secondary pericardial disease: an Australian population-based retrospective cohort studyTimothy Nathan Kwan, Jayant Ravindran, Gemma Kwan, et al.Journal of Clinical Medicine|June 26, 2025
Cause-Specific Mortality in Patients Hospitalized for Myocarditis from 2004 to 2021: A Retrospective Statewide Population-Linkage StudyTimothy N Kwan, Jayant Ravindran, Noor Alsadat, et al.Internal Medicine Journal|June 26, 2026
Thirty-day mortality among patients admitted due to acute myocardial infarction during the dates of the Cardiac Society of Australia and New Zealand Annual Scientific MeetingTimothy Nathan Kwan, Richa Malhotra, David Brieger, et al.The Medical Journal of Australia|November 13, 2014
Optimising acute care and secondary prevention for patients with acute coronary syndromeDavid BriegerAustralian Family Physician|May 6, 2014
Anticoagulation: a GP primer on the new oral anticoagulantsDavid BriegerClinical Cardiology|January 28, 2004
Optimizing adjunctive antithrombotic therapy in the treatment of acute myocardial infarction: a role for low-molecular-weight heparinDavid BriegerThe American Journal of Cardiology|July 31, 2012
Antithrombotic strategies to reduce adverse clinical outcomes in patients with acute coronary syndromeDavid BriegerPageof 23